LUND, Sweden, April 25, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a ...
Please provide your email address to receive an email when new articles are posted on . Visual field defects, afferent pupillary defects and abnormal optic discs were associated with positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback